CRR_Call Tracker

Text/HTML

Text/HTML

ValueProductView

ValueProductPastPerformance

Company NameReco DateReco PriceExit PriceExit Date% ReturnIn days
ITC Ltd. 28/12/2023464.20487.5002/01/2025 5.02% 1 yrs
Britannia Industries Ltd. 27/07/20234,875.805,028.2512/11/2024 3.13% 1 yrs
JSW Steel Ltd. 22/02/2024826.951,003.0026/09/2024 21.29% 217 days
Bajaj Auto Ltd. 22/08/20249,910.0011,930.0017/09/2024 20.38% 26 days
Dr. Reddy's Laboratories Ltd. 26/10/20235,429.306,536.0005/07/2024 20.38% 253 days
Shriram Finance Ltd. 25/04/20242,430.102,955.0028/06/2024 21.60% 64 days
Coal India Ltd. 25/01/2024389.50501.6022/05/2024 28.78% 118 days
Infosys Ltd. 27/10/20221,522.601,411.6019/04/2024 -7.29% 1 yrs
State Bank Of India 25/05/2023581.30782.0505/03/2024 34.53% 285 days
The Indian Hotels Company Ltd. 24/08/2023401.85517.9007/02/2024 28.88% 167 days

CRR_MVC_PastPerformance

Text/HTML

Our Other Trader Products

EasyDNNNews

Pharma Major Shares Rebound from Lows; Firm Reports 39.5 per cent Profit Growth

The company reported a net income of Rs 8,552 crore, marking a 39.5 per cent YoY growth. Total sales increased 10.6 per cent YoY to Rs 56,186 crore from Rs 50,799 crore in Q3 FY24

DSIJ Intelligence 0 231 Article rating: 5.0

The company reported a net income of Rs 8,552 crore, marking a 39.5 per cent YoY growth. Total sales increased 10.6 per cent YoY to Rs 56,186 crore from Rs 50,799 crore in Q3 FY24

This pharma company stock went 8 per cent high, do you own it?

With its shares up 8 per cent, the Indian multinational pharmaceutical company posted a net profit of Rs 130 crore in the second quarter, while its turnover increased to Rs 4,145 crore.

DSIJ Intelligence 0 1406 Article rating: 5.0

This pharma company stock went 8 per cent high, do you own it?                                                                                                                                                                                                       With its shares up 8 per cent, the Indian multinational pharmaceutical company posted a net profit of Rs 130 crore in the second quarter, while its turnover increased to Rs 4,145 crore.

A Volatile End: Nifty closes below 18,200 amid volatility; Realty, Pharma and metals take a hit

Nifty PSU Bank (+3.93 per cent) emerged as the top performers amongst the sectoral indices.  

DSIJ Intelligence 0 974 Article rating: 3.5

NSE Nifty 50 index plunged 0.25 per cent to close below 18,200 level while Sensex slipped 150 points. Nifty Midcap and Nifty Smallcap closed lower by 0.74 per cent and 0.56 per cent respectively.

Overnight Digest: Watch out for these stocks on September 30

Keep an eye on these stocks for Friday's trading session.

DSIJ Intelligence 0 2607 Article rating: 4.4

The weakening global economic environment has spiked up the bond yields and dollar index, which fostered fears of recession. Fading the morning losses, the benchmark indices ended marginally lower with Nifty 50 closing 0.24 per cent down and Sensex ending lower by 0.33 per cent.  

Overnight Digest: Stocks to keep an eye on August 26

Keep an eye on these stocks for Friday's trading session.

DSIJ Intelligence 0 1531 Article rating: 4.6

At the time of the closing bell on Thursday, the markets eroded the day’s gains, ahead of the monthly expiry, dragged by IT, FMCG, and pharma stocks.  

 At day end, Sensex closed at 58,774.72, losing 310.71 points or 0.53 per cent whereas Nifty 50 was at 17,522.45, down by 82.50 points or 0.47 per cent.  

Overnight Digest: Stocks likely to be in focus on June 9

Realty index gained up to 1.88 per cent as RBI permitted rural cooperative banks to extend finance for a residential housing project to further augment credit flows to the housing sector.

DSIJ Intelligence 0 1141 Article rating: 3.3

On Wednesday, the benchmark indices remained under pressure post the repo rate hike. RBI hiked the key policy repo rate by 50 bps to 4.90 per cent whereas the markets were relieved, as there was no CRR hike. The repo rate hike by RBI is likely to impact the home loan borrowers, both the existing as well as the new ones. While the hike is positive for the banks and the NBFCs, it is likely to be a burden for the borrowers. 

Overnight Digest: Stocks to be kept an eye on May 20

On an intraday basis, India VIX jumped 10.15 per cent to settle at 24.56 level on Thursday.

DSIJ Intelligence 0 1104 Article rating: 3.7

Due to the global sell-off, the Indian equity markets traded under pressure with Sensex rattling 1,416.30 points or 2.61 per cent ending at 52,792.23 level while Nifty declining 430.90 points or 2.65 per cent at 15,809.40 level.  

Stocks below Rs 100: Only buyers seen in these scrips on May 19

At noon on Thursday, the core equity indices i.e., Sensex and Nifty 50 fell sharply as the global markets took a deep plunge after the earnings results of corporates like Target and Walmart failed to meet expectations by a large margin

DSIJ Intelligence 0 1012 Article rating: 3.6

At noon on Thursday, the core equity indices i.e., Sensex and Nifty 50 fell sharply as the global markets took a deep plunge after the earnings results of corporates like Target and Walmart failed to meet expectations by a large margin

Overnight Digest: Stocks likely to be in focus on May 2

A flinch in the US economy and rate hike expectations in the upcoming Fed meet led to sell-off in the global market.

DSIJ Intelligence 0 1245 Article rating: 4.4

The benchmark indices erased the intraday gains and ended in red with Sensex plunging 460.19 points or 0.8 per cent at 57,060.87 level and Nifty ending 142.5 points or 0.83 per cent lower at 17,102.55 level.  

Lupin hit the ball out of the park! Is the tide turning in favour of the stock after this big announcement?

DSIJ Intelligence 0 735 Article rating: 3.7

Another interesting point is that it’s not very usual these days to see pharma stock jumping 8-9 per cent but on Tuesday, Lupin broke this jinx as it soared nearly 9 per cent. Certainly, this might have brought a million-dollar smile to the faces of Lupin investors.  

RSS

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR